|1.||Harb, H: 1 article (03/2015)|
|2.||Joeris, T: 1 article (03/2015)|
|3.||Martinic, V: 1 article (03/2015)|
|4.||Pfefferle, P I: 1 article (03/2015)|
|5.||Vachharajani, N: 1 article (03/2015)|
|6.||Visekruna, A: 1 article (03/2015)|
|7.||Hartmann, S: 1 article (03/2015)|
|8.||Hofer, M J: 1 article (03/2015)|
|9.||Steinhoff, U: 1 article (03/2015)|
|10.||Linnerz, T: 1 article (03/2015)|
|1.||Hodgkin Disease (Hodgkin's Disease)
09/01/2004 - "The aim of this study was to investigate c-Rel protein expression patterns in cHL and nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) cases by immunohistochemical analysis. "
09/01/2004 - "Our results demonstrate that there is differential c-REL protein expression in cHL in comparison with NLPHL and suggest that c-REL may play a role in the pathogenesis of classic Hodgkin lymphoma."
09/01/2004 - "Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma."
05/01/2003 - "Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma."
|2.||Retinoblastoma (Glioblastoma, Retinal)
04/01/1994 - "(i) c-rel proteins bearing any of three single-amino-acid mutations present in the N-terminal portion of v-rel were sufficiently oncogenic to induce tumor development in the absence of additional mutations. "
04/01/1994 - "All birds developed tumors, and all cell lines established from REV-C-induced tumors expressed c-rel proteins that lacked C-terminal sequences. "
|4.||Marek Disease (Marek's Disease)
|1.||Caspase 3 (Caspase-3)
|2.||Messenger RNA (mRNA)
|3.||Proteins (Proteins, Gene)
|4.||Immune Sera (Antisera)